Clinical Trial

Evaluation of the Pharmacokinetics of Curcumin Capsules in Healthy Human

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2026 (before its estimated February 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
Main objective: Through blood drug concentration testing, evaluate the post-meal pharmacokinetic characteristics of the curcumin product compared to similar products, and assess the differences in body exposure between the self-developed product and the control product in healthy trial participants. Secondary objective: Observe the safety of the self-developed product and the control product in healthy trial participants. Study population: Healthy male individuals or non-pregnant non-lactating females
Trial Details
NCT Number NCT07379177
Lead Sponsor Kingdomway (Inner Mongolia) Nutritional Food Co., Ltd.
Conditions Healthy
Enrollment 12 participants
Start Date 2026-01-28
Primary Completion 2026-02-07 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-30